Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

PURPOSE: CD19 chimeric antigen receptor (CD19-CAR) T cells induce high response rates in children and young adults (CAYAs) with B-cell acute lymphoblastic leukemia (B-ALL), but relapse rates are high. The role for allogeneic hematopoietic stem-cell transplant (alloHSCT) following CD19-CAR T-cell the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Oncol
Hauptverfasser: Shah, Nirali N., Lee, Daniel W., Yates, Bonnie, Yuan, Constance M., Shalabi, Haneen, Martin, Staci, Wolters, Pamela L., Steinberg, Seth M., Baker, Eva H., Delbrook, Cindy P., Stetler-Stevenson, Maryalice, Fry, Terry J., Stroncek, David F., Mackall, Crystal L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wolters Kluwer Health 2021
Schlagworte:
ORIGINAL REPORTS
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274806/
https://ncbi.nlm.nih.gov/pubmed/33764809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.02262
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge